GEN - Genetic Engineering and Biotechnology News

10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit

Genomics and Harvard University have sued Element Biosciences, alleging that Element’s AVITI24™ multiomics platform, Teton ...
Business Wire

Phase Genomics Collaborates with Element Biosciences to Optimize Cytogenomics for Liquid and Solid Tumor Samples

SEATTLE & SAN DIEGO--(BUSINESS WIRE)--Phase Genomics, Inc., a leading developer of cutting-edge genomic solutions, and Element Biosciences, the developer of an innovative DNA sequencing platform ...
FierceBiotech

Element Biosciences acquires Loop Genomics to add long-read tech to DNA sequencing platform

Element Biosciences hasn’t even launched its first benchtop DNA sequencing platform yet, but that hasn’t stopped it from raising hundreds of millions of dollars and, now, using that funding to acquire ...
STAT

Element Biosciences, an Illumina rival, on its genomics ambitions — and why it hasn’t gone public

SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several firms reporting that their growth has slowed, stalled, or reversed. Upstart ...
Seeking Alpha

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
Nasdaq

QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System

Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...
Morningstar

biomodal and Element Biosciences Combine Duet Multiomic and High-Throughput Sequencing Capabilities to Advance Clinical Research

biomodal, an omics-based life sciences technology and analytics company, today announced at the AGBT 2026 General Meeting that biomodal’s duet multiomic solutions are compatible with Element ...
Benzinga.com

STAT+: Element Biosciences, an Illumina rival, on its genomics ambitions — and why it hasn't gone public

SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several firms reporting that their growth has slowed, stalled, or reversed. Upstart ...